Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia

BACKGROUND: In Jimma Zone, Ethiopia, the first-line treatment of uncomplicated falciparum malaria has been changed from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (AL) in 2006. The objective of this study was to assess the effectiveness of AL in Jimma Zone two to three years after it...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshetu, Teferi, Abdo, Nasir, Bedru, Kunuz H, Fekadu, Sintayehu, Wieser, Andreas, Pritsch, Michael, Löscher, Thomas, Berens-Riha, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438107/
https://www.ncbi.nlm.nih.gov/pubmed/22824059
http://dx.doi.org/10.1186/1475-2875-11-240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438107/
https://www.ncbi.nlm.nih.gov/pubmed/22824059
http://dx.doi.org/10.1186/1475-2875-11-240

Ejemplares similares